As Managing Partner, Ryan is responsible for management, strategic planning and growth for all areas of Zazove Associates. Ryan is a key member of the investment team and has over 20 years of financial services industry experience, most recently with Wells Fargo Asset Management / Analytic Investors where he was Head of Factor Solutions, a business that he launched and ran after Wells Fargo Asset Management acquired Analytic Investors LLC. Before joining Analytic in 2010, Ryan was a Portfolio Manager at Northrop Grumman where he was responsible for managing the firm's Defined Benefit and Defined Contribution equity investments. Prior to Northrop Grumman, Ryan was responsible for conducting asset allocation and investment manager due diligence for Wilshire Associates' Funds Management Group. Ryan received a B.A. in Law and Society & Political Science from the University of California, Santa Barbara, and has earned the right to use the Chartered Alternative Investment Analyst designation.

Sector Gamma – Founder and Chief Investment Officer
Prior to joining Sector in 2005, Trond Horneland was Head of Global Healthcare at DNB Asset Management in Norway, where he was responsible for managing all of DNB’s global healthcare investments. He joined DNB in 1998 as an analyst/portfolio manager covering the healthcare sector. Mr. Horneland holds a master’s degree from the Norwegian School of Economics and Business Administration.

Company description:
Sector Gamma is a partner-owned and independent investment firm with five dedicated employees based in Norway and the United States. The company was established in 2006 and is licensed as an Alternative Investment Fund Manager (AIFM).
Sector Gamma’s operational efforts are outsourced to our long-term partner, Sector Asset Management. The Sector Asset Management group was founded in 1999 and oversees about USD 4bln across various niche strategies.

The Sector Healthcare Value Fund is a global long-only equity fund, seeking alpha from stock selection, together with full beta exposure, in the global healthcare sector. The objective of the fund is to achieve competitive long-term absolute returns and to outperform the returns of the MSCI Health Care index. The fund has an overall rating of 5 stars by Morningstar and is a UCITS fund registered in Ireland. Sector Healthcare Value Fund’s ambition is to add value through active and fundamentally based stock selection strategies. A long-term valuation driven approach is applied in selecting stocks, and we believe there is true value in having a rigorous and disciplined approach to portfolio construction and risk management.

Over his 25+ year investment career, Tom Ricketts has demonstrated a track record of adding value and gained in-depth portfolio management and research experience, including domain expertise across technology, healthcare, consumer, and other growth and innovation-focused industries.

Prior to founding Evolutionary Tree in 2017, Tom joined Sands Capital in 1994 during the startup phase, working to build out the research effort and team, and later, building and leading the Life Sciences Sector Team, overseeing ~$5B of investments.

From 2008-2016, Tom was a Sr. Portfolio Manager on Sands Capital’s flagship Select Growth strategy, a $20+ billion concentrated strategy of high-quality, sustainable growth businesses. In 2011, he joined the Executive Management Team, and in 2013, he became a member of the three-person Directing Research Team, which provided oversight of the 40-person global investment team.

Company and Strategy Description:
Evolutionary Tree specializes in innovation-focused, concentrated-growth investing. The investment philosophy is based on the belief that wealth creation is driven by profound innovation that powers the evolution of technology, business models, industries, and the economy. The objective is to identify the most important innovations, understand how these cause secular growth and evolutionary shifts, and ultimately, own the leading innovators.

Evolutionary Tree’s Humboldt Global Innovators strategy, launched in 2018, is a conviction-weighted, best-ideas global portfolio seeking to own the leaders within attractive innovation clusters around the world—special geographic locations where knowledge, talent and capital are abundant. There is also selective focus on countries with strong governance, while avoiding autocracies. The strategy adds value by owning the “crown jewel” leaders that launch a series of innovations that sustain growth and take share from competitors over time, benefiting from stacked S-curves, deep innovation pipelines, and layers of competitive advantage. In an innovation-driven economy, leaning into these types of businesses is critical for navigating change and harnessing important innovations.

Ali Chabaane is the founder and CEO of Fastnet AMS, a fintech that applies behavioural science to investment decision-making. With more than 25 years in the industry, he has led teams and strategies at global institutions including BNP Paribas and Pioneer Investments, where he earned a reputation for combining quantitative rigour with behavioural insight to drive significant growth in assets and revenues.

About Fastnet AMS:
Founded in Dublin in 2019, Fastnet AMS provides behavioural analytics solutions that help portfolio managers and fund selectors measure, track, and improve their decisions. The goal is to raise the overall quality of active investment.

Its flagship platform, Skillmetrics™, analyses investment decisions to uncover strengths, highlight blind spots, and help managers gain clarity to deliver a competitive edge. It also provides fund selectors with insights into a manager’s skills, which can strengthen confidence in their ability to repeat past successes.

Fastnet AMS has also launched CoreValuesMetrics, a solution designed to align investment decisions with sustainability objectives. It helps managers measure their impact on key metrics while giving allocators clear themes to engage on—ensuring capital is deployed in line with desired long-term impact.